Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y S Cho

Showing results (11-20 of 327) with videos related to

Pageof 33
Sort By:
Cancer Research|November 15, 1991
Correspondence Re: Michiel M. Van Lookeren Campagne et al., 8-chloroadenosine 3',5'-monophosphate inhibits the growth of Chinese hamster ovary and molt-4 cells through its adenosine metabolite. Cancer Res., 51: 1600-1605, 1991Y S Cho-Chung
Journal of the National Cancer Institute|July 5, 1989
Site-selective 8-chloro-cyclic adenosine 3',5'-monophosphate as a biologic modulator of cancer: restoration of normal control mechanismsY S Cho-Chung
Pharmacology & Therapeutics|August 24, 1999
Antisense oligonucleotide inhibition of serine/threonine kinases: an innovative approach to cancer treatmentY S Cho-Chung
Biochemical Society Transactions|May 1, 1992
Suppression of malignancy targeting cyclic AMP signal transducing proteinsY S Cho-Chung
Journal of Cyclic Nucleotide Research|January 1, 1980
Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivoY S Cho-Chung
Advances in Cyclic Nucleotide Research|January 1, 1980
On the mechanism of cyclic AMP-mediated growth arrest of solid tumorsY S Cho-Chung
Idrugs : the Investigational Drugs Journal|August 16, 2005
Nucleic acid therapeutics--millennium conference. 8-11 January 2000, Clearwater Beach, FL, USAY S Cho-Chung
Antisense & Nucleic Acid Drug Development|May 21, 1998
CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growthY S Cho-Chung
Cancer Research|December 1, 1974
In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivativesY S Cho-Chung
Current Pharmaceutical Design|August 17, 2005
DNA drug design for cancer therapyY S Cho-Chung
Pageof 33

Showing results (11-20 of 327) with videos related to

Sort By:
Pageof 33
Cancer Research|November 15, 1991
Correspondence Re: Michiel M. Van Lookeren Campagne et al., 8-chloroadenosine 3',5'-monophosphate inhibits the growth of Chinese hamster ovary and molt-4 cells through its adenosine metabolite. Cancer Res., 51: 1600-1605, 1991Y S Cho-Chung
Journal of the National Cancer Institute|July 5, 1989
Site-selective 8-chloro-cyclic adenosine 3',5'-monophosphate as a biologic modulator of cancer: restoration of normal control mechanismsY S Cho-Chung
Pharmacology & Therapeutics|August 24, 1999
Antisense oligonucleotide inhibition of serine/threonine kinases: an innovative approach to cancer treatmentY S Cho-Chung
Biochemical Society Transactions|May 1, 1992
Suppression of malignancy targeting cyclic AMP signal transducing proteinsY S Cho-Chung
Journal of Cyclic Nucleotide Research|January 1, 1980
Hypothesis. Cyclic AMP and its receptor protein in tumor growth regulation in vivoY S Cho-Chung
Advances in Cyclic Nucleotide Research|January 1, 1980
On the mechanism of cyclic AMP-mediated growth arrest of solid tumorsY S Cho-Chung
Idrugs : the Investigational Drugs Journal|August 16, 2005
Nucleic acid therapeutics--millennium conference. 8-11 January 2000, Clearwater Beach, FL, USAY S Cho-Chung
Antisense & Nucleic Acid Drug Development|May 21, 1998
CRE-palindrome oligonucleotide as a transcription factor decoy and an inhibitor of tumor growthY S Cho-Chung
Cancer Research|December 1, 1974
In vivo inhibition of tumor growth by cyclic adenosine 3',5'-monophosphate derivativesY S Cho-Chung
Current Pharmaceutical Design|August 17, 2005
DNA drug design for cancer therapyY S Cho-Chung
Pageof 33